Search

This second volume of a two-volume set focuses on specific pathogens and their mechanisms of pathogenesis as well as diagnostics, therapeutics and various strategies in the event of biological attacks. This multidisciplinary book appeals to readers from various fields, including biodefense, biosafety & biosecurity, virology, neurology, molecular biology and genetic engineering, as well as infectious disease specialists. Further, the work is of interest to basic science and applied science research scholars and experts working in the area of high-consequence or select agent virology.

This book explores how potential bio-threats and risks may evolve post 9/11 given the rapid changes in biotechnology and synthetic biology. It also explores what role intelligence communities can play in understanding threats and risks. It argues that although bio-threats and risks are largely low probability and high impact in nature, intelligence in ‘Five Eyes'countries remain insufficiently prepared to understand them. This book identifies key areas where intelligence reforms need to take place including a more strategic and systematic collaboration between national security/law enforcement intelligence and the scientific community. It is aimed at intelligence analysts, those in the scientific community working on health security threats, policy makers and researchers working on biosecurity and bioterrorism threats and risks.

A History of Infectious Diseases and the Microbial World offers readers answers to specific questions, as well as the challenge of a narrative that will stimulate their curiosity and encourage them to ask questions about the theory, practice, and assumptions of modern medicine.This work provides a broad introductory overview of the history of major infectious diseases, including their impact on different populations, the recognition of specific causative agents, and the development of methods used to prevent, control, and treat them. By stressing the major themes in the history of disease, this book allows readers to relate modern concerns to historical materials. It places modern developments concerning infectious diseases within their historical context, illuminating the relationships between patterns of disease and social, cultural, political, and economic factors. Upon completing this volume, readers will be prepared to answer contemporary questions concerning the threat of newly-emerging infectious diseases, potentially devastating pandemics, and the threat of bioterrorism. One will gain a precise understanding of the nature of different kinds of pathogens, the unique mechanisms behind disease transmission, and the means used to control, prevent, and treat infectious disease. Although only a few of these deadly illnesses can be addressed in detail, those that are discussed include: malaria, leprosy, bubonic plague, tuberculosis, syphilis, diphtheria, cholera, yellow fever, poliomyelitis, HIV/AIDS, and influenza.

Biological warfare has, unfortunately, in the post 9/11 world become a significant topic of discussion in both the medical and lay presses. In the wake of the biological'letter bombs'containing anthrax spores, the possibility of biologic and/or toxic attacks on civilians in any part of the world became no longer a possibility. It is now part of common discussion and consciousness. This book presents the history of the topics and clinically relevant discussions on those high risk (Category A) diseases beyond anthrax as well as a number of infections and toxins at the Category B level. Importantly, in addition, the text includes sections on Public Health Infrastructure, Public Health Law, Surveillance, Mental Health Management and Media Role all of which relate to epidemics of any sort, not just intentional biological events. Beyond Anthrax: The Weaponization of Infectious Diseases is a product that should serve as a reference point for clinicians, epidemiologists and public health personnel to understand in practical detail many of the aspects of weapons of biowarfare as well as the appropriate responses to them.

Aims to bring together information concerning microbes with potential as bioterrorist weapons. This work is useful for microbiologists, including bacteriologists, virologists and mycologists, in academia, government laboratories, and research institutes, public health physicians, researchers and scientists.

In 2003, the President's budget for bioterrorism defense totalled more than $5 billion. Today, the nation's top academic scientists are scrambling to begin work to understand Bacillus anthracis and develop new vaccines and drugs. However, just five years ago, only the US Department of Defense (DOD) seemed concerned about these “exotic” agents. In 1997, the DOD spent approximately $137 million on biodefense to protect the deployed force, while academe, industry, local governments, and most of our federal leadership was oblivious to, and in some cases doubtful of, the seriousness of the threat. The National Institutes of Health (NIH) received the largest budget increase in the organization's history. Fortunately, during this time of national urgency, a sound base exists on which to build our defenses against this new threat. A relatively small cadre of dedicated scientists within the US Army Medical Research and Materiel Command (USAMRMC) laid this foundation over the past 20 years.